Saturday, August 22, 2026
ExploreSearch
Via News
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Platforms Rush to Establish Content-Authenticity Standards Amid Leadership Shakeups and Sustained Capex
Within days of each other in mid-August 2026, Google, Anthropic, and Spotify moved to formalize AI content watermarking and labeling policies, signaling an industry-wide push toward self-governed provenance standards as generative AI output floods consumer platforms. The shift coincides with executive turnover at OpenAI (Brad Lightcap's departure) and Meta's public AI manifesto, all set against continued heavy AI infrastructure capital expenditure and finance-sector moves (e.g., Wall Street paying for algorithmic edges on social signals) that underscore AI's deepening entanglement with capital markets.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts report JPMorgan Chase & Co.'s revenue for the same fiscal period (FY 2025) with the same observation date (2025-12-31), but with different values: $182.447 billion vs. $185 billion. The ~1.4% difference ($2.553 billion) is too large to be explained by rounding alone and represents conflicting data for the identical time period.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,977
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,977 facts checked against source5,242 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 11, 2026

Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica

View original at finance.yahoo.com
Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment Says Astute Analytica AstuteAnalytica India Pvt…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • North America dominated the global market, accounting for the largest share of 47% in 2025

    80% confidence

  • The market is bifurcating, with innovation focused on severe phenotypes and smart delivery, while policy shifts mandate affordability for mass-market generic access

    80% confidence

  • Asthma accounts for 1.4 million emergency department visits and 94,000 hospital inpatient stays annually in the US

    80% confidence

  • The direct cost of asthma care is estimated at USD 3,728 per person annually

    80% confidence

  • 3,517 asthma deaths were reported in the most recent US data

    80% confidence

  • High-value biologic therapies are overtaking traditional treatments, driving revenue despite pricing pressures on standard inhalers

    80% confidence

  • India reports 34 million asthma cases, creating massive demand for affordable generic inhalers

    80% confidence

  • The global smart inhaler market was valued at USD 1.53 billion in 2024 and could reach USD 7.9 billion by 2030

    80% confidence

  • China's Volume-Based Procurement (VBP) has slashed generic prices by ~50%, forcing multinationals to abandon legacy generic margins in favor of introducing innovative biologics to the self-pay and private insurance tiers

    80% confidence

  • The FDA approved 50 novel drugs in 2024

    80% confidence

  • The global asthma drugs market size was valued at USD 26.52 billion in 2025 and is projected to hit the market valuation of USD 41.18 billion by 2035 at a CAGR of 4.50% during the forecast period 2026–2035

    80% confidence

  • There are 4.7 million children with asthma in the US, contributing to a total affected population of 24.9 million

    80% confidence

Cited in these Via News reports